Old Web
English
Sign In
Acemap
>
authorDetail
>
R. Swallow
R. Swallow
Boehringer Ingelheim
Medicine
Internal medicine
Endocrinology
Metformin
Diabetes mellitus
5
Papers
472
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial
2014
Diabetes, Obesity and Metabolism
Christopher S. Kovacs
V. Seshiah
R. Swallow
Russell Jones
Henning Rattunde
Hans-Juergen Woerle
Uli C. Broedl
Show All
Source
Cite
Save
Citations (276)
O14 La linagliptine améliore le contrôle glycémique chez les diabétiques de type 2 insuffisamment contrôlés par l’association metformine plus sulfonylurée, sans prise de poids ni hypoglycémie
2011
Diabetes & Metabolism
David Raymond Owens
R. Swallow
P Jones
Hans-Juergen Woerle
E. Tocque-Le-Gousse
Klaus Dugi
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of linagliptin in persons with Type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24‐week randomized study1
2011
Diabetic Medicine
David Raymond Owens
R. Swallow
Klaus Dugi
Hans-Juergen Woerle
Show All
Source
Cite
Save
Citations (196)
Linagliptin verbessert bei Typ-2-Diabetikern mit unzureichender Blutzuckerkontrolle durch Metformin und Sulfonylharnstoff die glykämische Kontrolle ohne Gewichtszunahme
2011
Diabetologie Und Stoffwechsel
T. Haak
N. Hermanns
Owens
R. Swallow
P Jones
Klaus Dugi
Hj Wörle
Show All
Source
Cite
Save
Citations (0)
O14 La linagliptine améliore le contrôle glycémique chez les diabétiques de type 2 insuffisamment contrôlés par l’association metformine plus sulfonylurée, sans prise de poids ni hypoglycémie
2011
Diabetes & Metabolism
David Raymond Owens
R. Swallow
P Jones
Hans-Juergen Woerle
E. Tocque-Le-Gousse
Klaus Dugi
Show All
Source
Cite
Save
Citations (0)
1